STRATA inks exclusive Mexico distribution deal; targets $300M acne, psoriasis, vitiligo market

STRATA Skin Sciences, Inc.

Three-year exclusive agreement with MINO Labs for distribution of TheraClearX, VTRAC, and XTRAC in Mexico.
STRATA gains access to nearly $300 million market for acne, psoriasis, and vitiligo treatments.
80% of Mexico's population is affected by low to severe acne, according to the release.
MINO Labs brings 20 years of pharmaceutical industry experience and deep Central/Latin America expertise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.